{'fraction_non_alphanumeric': 0.02275960170697013, 'fraction_numerical': 0.008534850640113799, 'mean_word_length': 4.915966386554622, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Action of dopamine on cyclic AMP-tissue level in the rat pancreas. Interaction with secretin.

Dopamine increased the cyclic AMP content of rat pancreas slices. It only partially displayed the agonist activity of secretin. Haloperidol 10(-4)M, a dopamine blocking agent almost completely inhibited the response to dopamine but had no effect on the response to secretin. Dopamine 10(-3)M, increased the cyclic AMP level induced by a low concentration of secretin and inhibited the production of cyclic AMP observed with a high concentration of secretin. Our data suggest that dopamine in the rat pancreatic tissue does not interfere with the secretin receptor but might act on the same adenylate cyclase.